<DOC>
	<DOCNO>NCT01493687</DOCNO>
	<brief_summary>The purpose study demonstrate CD5024 1 % cream effective vehicle apply daily , bed time , 12 week period subject Papulopustular Rosacea ( PPR ) continue safe 12 month .</brief_summary>
	<brief_title>Phase 3 Papulopustular Rosacea Study</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>1 . The subject papulopustular rosacea Investigator Global Assessment ( IGA ) score rat 3 ( moderate ) 4 ( severe ) , 2 . The subject least 15 70 inflammatory lesion ( papule pustule ) face . 1 . The subject particular form rosacea ( rosacea conglobata , rosacea fulminans , isolated rhinophyma , isolated pustulosis chin ) facial dermatosis may confound papulopustular rosacea , peri oral dermatitis , facial keratosis pilaris , seborrheic dermatitis , acne , 2 . The subject rosacea two nodule face .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>